Rob has been supporting Satsuma’s commercialization and business development activities since 2020 and joined as our Chief Commercial Officer in 2026. Rob has over 25 years of commercialization experience with more than 15 years in commercial leadership roles in both small and large pharmaceutical companies. Prior to joining Satsuma Pharmaceuticals, Rob served from 2016 to 2020 as the Vice President, Strategic Planning & Business Development for Durect Corporation. Before 2016, Rob was in senior commercial roles at various public pharmaceutical companies including ALZA, Jazz Pharmaceuticals, Johnson & Johnson and Wyeth Laboratories. Since entering the pharmaceutical industry in 1993, Rob has been responsible for the launch and commercialization of drugs for a variety of indications in the areas of women’s health, urology, pain management, CNS and metabolic disease. In several of these roles, Rob was the company’s first commercial hire with responsibility for building a commercial organization and launching its first product. Rob received a B.S. in biochemistry from the University of Vermont and holds an M.B.A. in finance and marketing from the Simon Business School at the University of Rochester.
« Back